Forbes·3 min read·medium
New Ebola Vaccine Enters Human Clinical Trials
V
Victoria Forster
✦AI Summary
Oxford University researchers have launched Phase I human clinical trials for a new vaccine targeting the Bundibugyo ebolavirus strain. This trial aims to address a critical gap in preparedness, as current licensed vaccines only protect against the Zaire strain.
Why it matters
Developing vaccines for diverse Ebola strains is essential for global health security, particularly in regions like the Democratic Republic of Congo where outbreaks occur.
Healthcare New Ebola Vaccine Enters Human Clinical Trials By Victoria Forster ,
healthscience
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in